Register for your FREE account now and join thousands of oncology professionals who stay informed about patient care issues, practical oncology-care management techniques, and drug administration and dosage information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Clinical Trials: Phase II Trial of High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma

January 06, 2010

Print
Email
Reprint
Text: A | A | A

More Kidney Cancer Clinical Trials

Web Exclusives

Posttransplant lenalidomide can slow down multiple myeloma

Delicia Honen Yard May 29, 2012

Lenalidomide use after autologous stem-cell transplant significantly improved progression-free and overall survival in patients with myeloma.

Melanoma genome study implicates sun and new genetic culprits

Delicia Honen Yard May 28, 2012

Genetic mutations increased along with chronic sun exposure in persons with melanoma, and yet another gene may contribute to disease risk as well.

Modified stem cells keep glioblastoma at bay

Delicia Honen Yard May 25, 2012

Three patients with glioblastoma lived longer than predicted after receiving transplants of their own blood stem cells that had been gene-modified.

Oncology Nurse Advisor Sitemap

Other Haymarket Medical Websites

MPR (drug database)

Clinical Advisor

JAAPA

myCME - Online CME

McKnights Long Term Care News

Renal and Urology News

Chemotherapy Advisor

International

GPonline

MIMS (drug database)

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions

Clinical Trials: Phase II Trial of High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma

More Kidney Cancer Clinical Trials

Web Exclusives

Posttransplant lenalidomide can slow down multiple myeloma

Delicia Honen Yard May 29, 2012

Melanoma genome study implicates sun and new genetic culprits

Delicia Honen Yard May 28, 2012

Modified stem cells keep glioblastoma at bay

Delicia Honen Yard May 25, 2012

Oncology Nurse Advisor Sitemap

News

Hot Topics

More

Focus on

Conference News

Resources

Departments

Archives

Other Haymarket Medical Websites

International